Eli Zuckerman

10.1k total citations · 1 hit paper
78 papers, 2.7k citations indexed

About

Eli Zuckerman is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Eli Zuckerman has authored 78 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Hepatology, 41 papers in Epidemiology and 14 papers in Rheumatology. Recurrent topics in Eli Zuckerman's work include Hepatitis C virus research (44 papers), Liver Disease Diagnosis and Treatment (31 papers) and Hepatitis B Virus Studies (19 papers). Eli Zuckerman is often cited by papers focused on Hepatitis C virus research (44 papers), Liver Disease Diagnosis and Treatment (31 papers) and Hepatitis B Virus Studies (19 papers). Eli Zuckerman collaborates with scholars based in Israel, United States and France. Eli Zuckerman's co-authors include Daniel Yeshurun, Elias Toubi, Tsila Zuckerman, Gleb Slobodin, Edmond Sabo, Janice Wahl, Michael Robertson, Jochanan E. Naschitz, Eliav Barr and Aharon Kessel and has published in prestigious journals such as The Lancet, Blood and Annals of Internal Medicine.

In The Last Decade

Eli Zuckerman

75 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

2015 477 citations Eli Zuckerman, Michael Robertson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eli Zuckerman Israel	27	1.9k	1.4k	460	361	328	78	2.7k
Yusuke Kawamura Japan	37	5.2k 2.8×	4.9k 3.6×	372 0.8×	413 1.1×	174 0.5×	263	6.2k
Howard F. Taswell United States	33	1.4k 0.7×	1.2k 0.9×	200 0.4×	104 0.3×	269 0.8×	105	3.4k
Jérôme Le Pavec France	30	418 0.2×	527 0.4×	205 0.4×	485 1.3×	524 1.6×	112	4.3k
Colin Tang Hong Kong	18	669 0.4×	432 0.3×	1.1k 2.3×	348 1.0×	56 0.2×	29	2.1k
María‐Carlota Londoño Spain	28	2.2k 1.2×	1.7k 1.2×	159 0.3×	270 0.7×	61 0.2×	125	2.9k
Daniele Vallisa Italy	23	585 0.3×	401 0.3×	98 0.2×	91 0.3×	506 1.5×	96	2.0k
Etsuko Hashimoto Japan	21	1.8k 1.0×	1.6k 1.2×	206 0.4×	46 0.1×	161 0.5×	55	2.3k
Aurélie Plessier France	36	3.4k 1.8×	2.2k 1.6×	315 0.7×	75 0.2×	655 2.0×	125	4.5k
Tomokazu Kawaoka Japan	25	1.6k 0.8×	1.2k 0.9×	82 0.2×	114 0.3×	30 0.1×	150	2.1k
Jeffrey Enejosa United States	18	409 0.2×	630 0.5×	515 1.1×	1.5k 4.2×	140 0.4×	45	2.6k

Countries citing papers authored by Eli Zuckerman

Since Specialization

Citations

This map shows the geographic impact of Eli Zuckerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Zuckerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Zuckerman more than expected).

Fields of papers citing papers by Eli Zuckerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Zuckerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Zuckerman. The network helps show where Eli Zuckerman may publish in the future.

Co-authorship network of co-authors of Eli Zuckerman

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Zuckerman. A scholar is included among the top collaborators of Eli Zuckerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Zuckerman. Eli Zuckerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zuckerman, Eli, Julio Gutiérrez, Andrew Ustianowski, et al.. (2019). THU-198-Efficacy and safety of glecaprevir/pibrentasvir treatment for 8 weeks in treatment-naive patients with chronic hepatitis C virus infection without cirrhosis or with compensated cirrhosis: Analysis of data pooled from phase 2 and 3 studies. Journal of Hepatology. 70(1). e251–e251. 1 indexed citations

Hazzan, Rawi, et al.. (2019). Twelve Weeks Treatment with Ombitasvir/Paritaprevir/ Ritonavir and Dasabuvir in Chronic Hepatitis C Genotype 2k/1b Patients is Highly Efficient and Safe. 3(1). 1 indexed citations

Süsser, S., Julia Dietz, Bernhard Schlevogt, et al.. (2017). Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras. Journal of Hepatology. 67(4). 680–686. 20 indexed citations

Brown, Ashley, Christophe Hézode, Eli Zuckerman, et al.. (2015). P0771 : C-SCAPE: Efficacy and safety of 12 weeks of grazoprevir +/- elbasvir +/- ribavirin in patients with HCV GT2, 4, 5 or 6 infection. Journal of Hepatology. 62. S619–S619. 12 indexed citations

Zuckerman, Eli, Rifaat Safadi, Ran Oren, et al.. (2012). [Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver].. PubMed. 151(12). 709–14, 719. 1 indexed citations

Rimar, Doron, Itzhak Rosner, Michael Rozenbaum, & Eli Zuckerman. (2011). Familial Mediterranean fever: an association with non-alcoholic fatty liver disease. Clinical Rheumatology. 30(7). 987–991. 16 indexed citations

Safadi, Rifaat, et al.. (2007). [516] A RANDOMIZED TRIAL OF SWITCHING TO TELBIVUDINE VERSUS CONTINUED LAMIVUDINE IN ADULTS WITH CHRONIC HEPATITIS B: RESULTS OF THE PRIMARY ANALYSIS AT WEEK 24. Journal of Hepatology. 46. S196–S197. 11 indexed citations

Sammour, Rami, Eli Zuckerman, Naveh Tov, & Ron Gonen. (2006). Pregnancy Exacerbating Hepatopulmonary Syndrome. Obstetrics and Gynecology. 107(Supplement). 455–457. 3 indexed citations

Miselevich, Ines, et al.. (2005). Nodular Regenerative Hyperplasia Associated with Idiopathic Thrombocytopenic Purpura in a Young Girl: A Case Report and Review of the Literature. Journal of Pediatric Gastroenterology and Nutrition. 41(2). 251–255. 13 indexed citations

10.

Sabo, Edmond, Luis Gaitini, Eli Zuckerman, et al.. (2004). Cardiovascular reactivity score for the assessment of dysautonomia in familial Mediterranean fever. Rheumatology International. 24(3). 147–152. 19 indexed citations

11.

Zuckerman, Eli, Gleb Slobodin, Edmond Sabo, et al.. (2003). Quantitative liver-spleen scan using single photon emission computerized tomography (SPECT) for assessment of hepatic function in cirrhotic patients. Journal of Hepatology. 39(3). 326–332. 32 indexed citations

12.

Groshar, David, Gleb Slobodin, & Eli Zuckerman. (2002). Quantitation of liver and spleen uptake of (99m)Tc-phytate colloid using SPECT: detection of liver cirrhosis.. PubMed. 43(3). 312–7. 23 indexed citations

13.

Toubi, Elias, Aharon Kessel, Lee E. Goldstein, et al.. (2001). Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: association with liver disease severity. Journal of Hepatology. 35(6). 774–780. 50 indexed citations

14.

Lurie, M., et al.. (2001). Metastatic small cell carcinoma presenting as acute hepatic failure. The American Journal of Gastroenterology. 96(12). 3471–3473. 3 indexed citations

15.

Zuckerman, Eli, Tsila Zuckerman, Dvora Sahar, et al.. (2001). bcl‐2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. British Journal of Haematology. 112(2). 364–369. 85 indexed citations

16.

Zuckerman, Eli, Tsila Zuckerman, Dvora Sahar, et al.. (2001). The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood. 97(6). 1555–1559. 45 indexed citations

17.

Kessel, Aharon, et al.. (2000). Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection.. PubMed. 27(3). 610–2. 25 indexed citations

18.

Keren, Dean, et al.. (1999). Myeloma ascites?a favorable outcome with cyclophosphamide therapy. American Journal of Hematology. 60(2). 140–142. 6 indexed citations

19.

Blüml, Stefan, et al.. (1998). Proton‐Decoupled ³¹P Magnetic Resonance Spectroscopy Reveals Osmotic and Metabolic Disturbances in Human Hepatic Encephalopathy. Journal of Neurochemistry. 71(4). 1564–1576. 52 indexed citations

20.

Yeshurun, Daniel, et al.. (1987). Massive hepatic steatosis complicating adult celiac disease: report of a case and review of the literature.. PubMed. 82(11). 1186–9. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact